ArticleCancers2024

The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses.

Naotoshi Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.